512 Stock Overview
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Grand Pharmaceutical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.26 |
| 52 Week High | HK$5.40 |
| 52 Week Low | HK$3.17 |
| Beta | 0.69 |
| 1 Month Change | 3.40% |
| 3 Month Change | 22.41% |
| 1 Year Change | -16.96% |
| 3 Year Change | -35.36% |
| 5 Year Change | -5.33% |
| Change since IPO | -83.62% |
Recent News & Updates
Recent updates
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25
We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Sep 26Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14
Jun 04Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?
Sep 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Jul 28Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11
May 29Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?
Apr 08Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late
Jan 24These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price
Nov 27With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting
Oct 25China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly
Sep 01Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?
Jul 12We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt
Apr 26Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)
Apr 08Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching
Mar 24If You Had Bought China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Shares Five Years Ago You'd Have Earned 332% Returns
Mar 11Are Robust Financials Driving The Recent Rally In China Grand Pharmaceutical and Healthcare Holdings Limited's (HKG:512) Stock?
Feb 22China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Are Growing But Is There More To The Story?
Jan 21Is China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512) Popular Amongst Insiders?
Jan 06
Does China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Deserve A Spot On Your Watchlist?
Dec 22Shareholder Returns
| 512 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 8.4% | 3.7% | 3.6% |
| 1Y | -17.0% | -17.6% | -10.1% |
Price Volatility
| 512 volatility | |
|---|---|
| 512 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.6% |
| 10% least volatile stocks in HK Market | 3.7% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 10,534 | Chao Zhou | www.grandpharm.com |
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It also manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products.
Grand Pharmaceutical Group Limited Fundamentals Summary
| 512 fundamental statistics | |
|---|---|
| Market cap | HK$14.92b |
| Earnings (TTM) | HK$1.88b |
| Revenue (TTM) | HK$10.53b |
7.9x
P/E Ratio1.4x
P/S RatioIs 512 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 512 income statement (TTM) | |
|---|---|
| Revenue | HK$10.53b |
| Cost of Revenue | HK$4.01b |
| Gross Profit | HK$6.52b |
| Other Expenses | HK$4.64b |
| Earnings | HK$1.88b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.54 |
| Gross Margin | 61.96% |
| Net Profit Margin | 17.85% |
| Debt/Equity Ratio | 21.8% |
How did 512 perform over the long term?
See historical performance and comparisonDividends
6.1%
Current Dividend Yield49%
Payout RatioDoes 512 pay a reliable dividends?
See 512 dividend history and benchmarks| Grand Pharmaceutical Group dividend dates | |
|---|---|
| Ex Dividend Date | Jun 06 2024 |
| Dividend Pay Date | Jun 27 2024 |
| Days until Ex dividend | 41 days |
| Days until Dividend pay date | 62 days |
Does 512 pay a reliable dividends?
See 512 dividend history and benchmarks